Edition:
United Kingdom

Sientra Inc (SIEN.OQ)

SIEN.OQ on NASDAQ Stock Exchange Global Select Market

9.49USD
21 Feb 2018
Change (% chg)

$-1.72 (-15.34%)
Prev Close
$11.21
Open
$10.68
Day's High
$10.68
Day's Low
$9.33
Volume
313,863
Avg. Vol
62,915
52-wk High
$16.61
52-wk Low
$7.21

Chart for

About

Sientra, Inc. is a medical aesthetics company. The Company's primary products are silicone gel breast implants for use in breast augmentation and breast reconstruction procedures, which it offers in over 190 variations of shapes, sizes and textures. The Company sells its breast implants and breast tissue expanders, or breast... (more)

Overall

Beta: --
Market Cap(Mil.): $307.56
Shares Outstanding(Mil.): 19.31
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 32.19 16.60
EPS (TTM): -- -- --
ROI: -- 13.90 10.66
ROE: -- 16.72 14.30

BRIEF-Sientra Says Co Enters Into Agreement With Stifel, Nicolaus & Co Inc

* SIENTRA SAYS CO ENTERED INTO AGREEMENT WITH STIFEL, NICOLAUS & CO INC, TO SELL SHARES OF STOCK HAVING AN OFFERING PRICE OF UP TO $50 MILLION- SEC FILING Source text for Eikon: Further company coverage:

20 Feb 2018

BRIEF-Sientra Provides Update On FDA Review Of U.S. Manufacturing Facility

* SIENTRA® PROVIDES UPDATE ON FDA REVIEW OF U.S. MANUFACTURING FACILITY

30 Jan 2018

BRIEF-Sientra Announces Preliminary Unaudited Q4 Revenue

* SIENTRA ANNOUNCES PRELIMINARY UNAUDITED FOURTH QUARTER 2017 REVENUE

08 Jan 2018

BRIEF-Sientra Inc Files For Mixed Shelf Of Upto $150 Million

* SIENTRA INC FILES FOR MIXED SHELF OF UPTO $150 MILLION - SEC FILING Source text (http://bit.ly/2ADjKzY) Further company coverage:

08 Jan 2018

BRIEF-Sientra posts qtrly loss of $0.74​ per share

* Total net sales for Q3 2017 were $9.8 million, compared to total net sales of $6.5 million for same period in 2016​

07 Nov 2017

BRIEF-Sientra's ‍total net sales for Q3 2017 were $9.8 million

* Sientra - ‍total net sales for Q3 2017 were $9.8 million, compared to $6.5 million for same period in 2016

07 Nov 2017

Competitors

  Price Chg
Allergan plc (AGN.N) $159.31 -1.28
Johnson & Johnson (JNJ.N) $129.91 -0.96

Earnings vs. Estimates